Acadia Pharmaceuticals Inc. (ACAD-Q)
NASDAQ:ACAD
14.83
0.03
(0.20%) 1d
Financials
Technical Analysis
This summary was created by AI, based on 1 opinions in the last 12 months.
Acadia Pharmaceuticals Inc. has gained attention in the pharmaceutical sector, particularly for its focus on central nervous system disorders. However, experts are expressing caution about the company's success with these specialized drugs, indicating that they are rare and often come with significant risks. The company's prospects appear to be overshadowed by the inherent challenges in developing treatments for complex neurological conditions. This sentiment suggests that while Acadia has potential, the market may be viewing it with skepticism due to the unpredictable nature of drug development and approval in this area. Investors might need to take a closer look at the risks involved before making a financial commitment.
There has been a little volatility. The long-term moving average is going up nicely from early 2016. In 2015, it got a little overextended, which can happen from time to time. Chart shows a long downtrend line which was recently broken. The biotech sector is the right space. He believes, on a fundamental basis, that we are just scratching the surface on what biotech is going to do and how it is going to change humanity. Believes it will be a game changer. This name looks like it is breaking out. A little steep right now, but looks like it wants to go much higher and hit around $60.
This is a smaller company between $3-$4 billion and volatile. Have been working on central nervous system and Parkinson’s. This would be the 1st marketable drug for this company. Recently got a favourable FDA ruling. Things are going in the right direction. These things can go way up or way down, and is not his type of investment. If you want to take a flyer, he would encourage you to look at it as something that shouldn’t be core to your portfolio.
- «
- ‹
- 1
- ›
- »
Acadia Pharmaceuticals Inc.(ACAD-Q) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 1
Acadia Pharmaceuticals Inc.(ACAD-Q) Frequently Asked Questions
What is Acadia Pharmaceuticals Inc. stock symbol?
Acadia Pharmaceuticals Inc. is a American stock, trading under the symbol ACAD-Q on the NASDAQ (ACAD). It is usually referred to as NASDAQ:ACAD or ACAD-Q
Is Acadia Pharmaceuticals Inc. a buy or a sell?
In the last year, 1 stock analyst published opinions about ACAD-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Acadia Pharmaceuticals Inc..
Is Acadia Pharmaceuticals Inc. a good investment or a top pick?
Acadia Pharmaceuticals Inc. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Acadia Pharmaceuticals Inc..
Why is Acadia Pharmaceuticals Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Acadia Pharmaceuticals Inc. worth watching?
1 stock analyst on Stockchase covered Acadia Pharmaceuticals Inc. In the last year. It is a trending stock that is worth watching.
What is Acadia Pharmaceuticals Inc. stock price?
On 2025-04-15, Acadia Pharmaceuticals Inc. (ACAD-Q) stock closed at a price of $14.83.
Success from nervous central drugs so rare. Too risky.